The broken lines illustrate portions of the glucose monitoring skin patch that form no part of the claimed design.
The broken lines illustrate portions of the glucose monitoring skin patch that form no part of the claimed design.
Number | Name | Date | Kind |
---|---|---|---|
D719267 | Vaccarella | Dec 2014 | S |
D794201 | Newhouse | Aug 2017 | S |
D794801 | Newhouse | Aug 2017 | S |
20060202859 | Mastrototaro | Sep 2006 | A1 |
20110160669 | Gyrn | Jun 2011 | A1 |
20120136300 | Schoonmaker | May 2012 | A1 |
20130267811 | Pryor | Oct 2013 | A1 |
20140275881 | Lamego | Sep 2014 | A1 |
20140276576 | Cole | Sep 2014 | A1 |
20160157759 | Yang | Jun 2016 | A1 |
20160287150 | Yu | Oct 2016 | A1 |
20170112534 | Schoonmaker | Apr 2017 | A1 |
20170188912 | Halac | Jul 2017 | A1 |
Entry |
---|
Bergan, Mark et al., “Dexcom Has a Big Ally if Apple Gets Into Its Corner of the Diabetes Market”, Bloomberg News, Apr. 19, 2017, Retrieved from the internet https://www.bloomberg.com/news/articles/2017-04-19/dexcom-has-a-big-ally-if-apple-gets-into-its-corner-of-the-diabetes-market, 5 pages. |
Notice of Preliminary Rejection issued for Korean Application No. 30-2017-43709, dated Mar. 22, 2018, 5 pages. |
First Examiner's Report issued for Canadian Application No. 177694 dated Jun. 15, 2018, 1 page. |